Tempest Therapeutics, Inc. (TPST)
NASDAQ: TPST · Real-Time Price · USD
0.6324
+0.0082 (1.31%)
Oct 19, 2026, 10:52 AM EDT - Market open
Tempest Therapeutics Employees
Tempest Therapeutics had 4 employees as of June 30, 2026. The number of employees decreased by 17 or -80.95% compared to the same quarter last year. That makes Tempest Therapeutics the 42,415th largest employer in the world and 6,773rd in the United States.
Employees
4
Change
-17
Growth
-80.95%
Revenue / Employee
n/a
Profits / Employee
-$10,118,000
Market Cap
10.46M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 4 | -17 | -80.95% |
| Mar 31, 2026 | 5 | -19 | -79.17% |
| Dec 31, 2025 | 4 | -20 | -83.33% |
| Sep 30, 2025 | 5 | -19 | -79.17% |
| Jun 30, 2025 | 21 | - | - |
| Dec 31, 2024 | 24 | 7 | 41.18% |
| Dec 31, 2023 | 17 | -2 | -10.53% |
| Dec 31, 2022 | 19 | 2 | 11.76% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Pluri | 113 |
| CytoMed Therapeutics | 42 |
| Palatin Technologies | 25 |
| BioLineRx | 24 |
| Passage Bio | 24 |
| IN8bio | 18 |
| Cellectar Biosciences | 11 |
| Ensysce Biosciences | 10 |
TPST News
- 3 days ago - Tempest Therapeutics Proxy statement: Proxy filing - Filings
- 4 days ago - Tempest Therapeutics Transcript: AGM 2026 - Transcripts
- 5 days ago - Tempest Appoints John W. Frederick to Board of Directors, Strengthening Financial and Capital Markets Expertise - GlobeNewsWire
- 23 days ago - Tempest Therapeutics files to sell 9.53M shares of common stock for holders - TheFly
- 24 days ago - Tempest Therapeutics Registration statement: Registration filing - Filings
- 24 days ago - Tempest Therapeutics price target lowered to $7 from $11 at H.C. Wainwright - TheFly
- 26 days ago - Tempest Therapeutics appoints Freda-Smith to board of directors - TheFly
- 26 days ago - Tempest Appoints Global Finance Leader Nancy Freda-Smith to Board of Directors - GlobeNewsWire